Literature DB >> 26728936

Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study.

K P G M Hurkens1, C Mestres-Gonzalvo, H A J M de Wit, P H M van der Kuy, R Janknegt, F Verhey, J M G A Schols, C D A Stehouwer, B Winkens, W Mulder.   

Abstract

OBJECTIVES: To establish the quality of medication reviews performed by nursing home physicians, general practitioners and pharmacists. DESIGN AND
SETTING: 15 Pharmacists, 13 general practitioners and 18 nursing home physicians performed a medication review for three cases (A, B and C), at three evaluation moments. First, they received the medication list. Secondly, they also received laboratory results and reason for admission and finally, we added medical history. Remarks were divided into 6 categories, i.e. indication without medication, medication without indication, contraindications/ interactions, dosage problems, double medication and wrong medication. Remarks were compared to the remarks made by our expert panel and scored according to our grading model as appropriate (0 to +3) or missed or potentially harmful (-1). For each medication error category, the percentage of participants who made this error was computed.
RESULTS: After the first evaluation moment, the overall estimated mean percentage score was -1.7% for case A, 3.9% for case B, and 8.7% for case C. After the second review, this score was 15.0% for case A, 19.8% for case B, and 22.2% for case C. This further increased to 30.0% for case A, 36.7% for case B and 44% for case C at the final evaluation. The absence of medication where there was an indication (indication without medication) was frequently missed and did not improve after adding the extra information regarding laboratory results, reason for admission and finally medical history.
CONCLUSION: Increasing clinical information helps physicians and pharmacists to improve their medication reviews, however, additional information was still related with a high margin of error. Detection of certain errors becomes easier with additional information, whereas other errors remain undetected. To achieve a high standard of medication review, we have to change the way medication reviews should be performed.

Entities:  

Mesh:

Year:  2016        PMID: 26728936     DOI: 10.1007/s12603-016-0678-1

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  28 in total

1.  Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial.

Authors:  L Furniss; A Burns; S K Craig; S Scobie; J Cooke; B Faragher
Journal:  Br J Psychiatry       Date:  2000-06       Impact factor: 9.319

Review 2.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Susan M Patterson; Carmel Hughes; Ngaire Kerse; Chris R Cardwell; Marie C Bradley
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria.

Authors:  P F Gallagher; M N O'Connor; D O'Mahony
Journal:  Clin Pharmacol Ther       Date:  2011-04-20       Impact factor: 6.875

Review 4.  Clinical pharmacists and inpatient medical care: a systematic review.

Authors:  Peter J Kaboli; Angela B Hoth; Brad J McClimon; Jeffrey L Schnipper
Journal:  Arch Intern Med       Date:  2006-05-08

5.  Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy.

Authors:  Doron Garfinkel; Derelie Mangin
Journal:  Arch Intern Med       Date:  2010-10-11

6.  Contribution of adverse drug reactions to hospital admission of older patients.

Authors:  C K Mannesse; F H Derkx; M A de Ridder; A J Man in 't Veld; T J van der Cammen
Journal:  Age Ageing       Date:  2000-01       Impact factor: 10.668

7.  Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people.

Authors:  J Allard; R Hébert; M Rioux; J Asselin; L Voyer
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

8.  Patient focused drug surveillance of elderly patients in nursing homes.

Authors:  Inger Nordin Olsson; Bengt Curman; Peter Engfeldt
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-02       Impact factor: 2.890

Review 9.  Studies to reduce unnecessary medication use in frail older adults: a systematic review.

Authors:  Jennifer Tjia; Sarah J Velten; Carole Parsons; Sruthi Valluri; Becky A Briesacher
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

10.  START (screening tool to alert doctors to the right treatment)--an evidence-based screening tool to detect prescribing omissions in elderly patients.

Authors:  P J Barry; P Gallagher; C Ryan; D O'mahony
Journal:  Age Ageing       Date:  2007-09-19       Impact factor: 10.668

View more
  3 in total

1.  The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance.

Authors:  Claudia Greißing; Katharina Kössler; Johanna Freyer; Lucie Hüter; Peter Buchal; Susanne Schiek; Thilo Bertsche
Journal:  Int J Clin Pharm       Date:  2016-10-25

2.  Drug Prescription Including Interactions with Anticancer Treatments in the Elderly: A Global Approach.

Authors:  M-E Rougé Bugat; M Bourgouin; S Gérard; S Lozano; D Brechemier; P Cestac; C Cool; L Balardy
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Pharmacist-led medication reviews for geriatric residents in German long-term care facilities.

Authors:  Kerstin Bitter; Christina Pehe; Manfred Krüger; Gabriela Heuer; Regine Quinke; Ulrich Jaehde
Journal:  BMC Geriatr       Date:  2019-02-11       Impact factor: 3.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.